Skip to main content

Advertisement

Fig. 7 | Clinical Epigenetics

Fig. 7

From: Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

Fig. 7

Promoter ASB2 region gaining methylation in knockouts exhibits hypermethylation in prostate tumor samples compared to matched normal prostate. Scatterplot depicting increased methylation in matched tumor and normal samples (n = 18 per group), with mean and SEM depicted with error bars. Significance determined by paired Wilcoxon signed-rank test with continuity correction

Back to article page